Skip to main content
. 2020 Jul 29;20:697. doi: 10.1186/s12913-020-05556-0

Table 2.

HIV / family planning related SRHS Available at the surveyed health facilities

Variables Total YES
n (%)
NO
n (%)
STDs testing 159 145(91.2) 14(8.8)
STDs treatment 159 103(64.8) 56(35.2)
HIV testing 159 137(86.2) 22(13.8)
HIV self-testing 156 39(25) 117(75.0)
HIV Self-testing kits 157 31(19.7) 126(80.3)
HIV same-day therapy initiation 157 66(42) 91(58)
HIV treatment 158 50(31.6) 108 (68.4)
HIV counselling 158 127(80.4) 31(19.6)
Circumcision 159 102(64.2) 57(35.8)
Contraceptives 159 136(85.5) 23(14.5)
Combined oral contraceptive 157 123(78.3) 34(21.7)
Progesterone contraceptive 155 117(75.5) 38(24.5)
Emergency contraception 158 101(63.9) 57(36.1)
Depo Provera injection 150 99(66) 61 (34.0)
Implant 153 82(53.6) 71(46.4)
Intrauterine Device (IUD) 155 76(49) 79(51)
Male condom 159 117(73.6) 42(26.4)
Female condoms 157 33(21) 124(79)
Lubricants 156 22(14.1) 134(85.9)
Vasectomy 157 18(11.5) 139(88.5)
Tubal ligation 156 34(21.8) 122(78.2)
Fertility awareness 158 82(51.9) 76(48.1)
Antenatal Care (ANC) 157 75(47.8) 85(52.2)
Post-natal care 157 70(44.6) 87(55.4)